Ovarian carcinoma (HGSOV): Continue with Zejula (Niraparib) or not?
Hi, I'me new on this group. I have HGSOV diagnosed in november 2019. Since then, exept from 11 months in remission after debulking surgery and first line of standard chemo (carbo+taxol), I'm on constant meds (3 rounds of chemo – Carbo, taxol, Caelyx, Avastin) and now I've started the maintenance therapy with Zejula (Niraparib). Recently I've learned that Zejula has been withdrawn by GKS for patients after II or III line of treatments and with positive HDR (which is ma case) as ineffective. I live in Europe – Switzerland and I wonder if I should continue with Niraparib (which here is still allowed) or not?